# Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients

> **NCT05981326** · NA · RECRUITING · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Blood samples
- **BEHAVIORAL:** Questionnaires

## Key facts

- **NCT ID:** NCT05981326
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-31
- **Primary completion:** 2028-04
- **Final completion:** 2033-04
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05981326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05981326, "Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05981326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
